(58 days)
Not Found
No
The summary describes a mechanical device (balloon catheter) and does not mention any software, algorithms, or data processing that would indicate the use of AI/ML.
Yes
The device is intended for temporary vessel occlusion and emergency control of hemorrhage, which are direct interventions for treating a medical condition or preventing further harm.
No
The device is described as an "Occlusion Balloon" for temporary vessel occlusion, hemorrhage control, and perioperative occlusion. Its function is to perform a physical action (occlusion), not to diagnose a condition or disease.
No
The device description clearly describes a physical catheter with a balloon, lumens, and radiopaque markers, indicating it is a hardware medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health. This includes tests performed in a laboratory or at the point of care.
- Device Function: The Bridge Occlusion Balloon catheter is designed to be inserted directly into the superior vena cava (SVC) within the body to physically occlude the vessel. It is a therapeutic device used for temporary blockage, not for analyzing biological samples.
- Intended Use: The intended use clearly states "temporary vessel occlusion" and "emergency control of hemorrhage," which are interventional procedures performed directly on the patient.
- Device Description: The description focuses on the physical components of the catheter and balloon for insertion and inflation within the body.
- Lack of IVD Indicators: There is no mention of analyzing samples, laboratory procedures, or diagnostic testing in the provided text.
Therefore, the Bridge Occlusion Balloon catheter is a therapeutic medical device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The Bridge Occlusion Balloon catheter is indicated for use for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage.
Any use for procedures other than those indicated in the instructions is not recommended.
Product codes
MJN
Device Description
The Bridge Occlusion Balloon is designed to be delivered percutaneously to the superior vena cava (SVC) for the purpose of providing occlusion of the SVC and providing emergency control of hemorrhage and perioperative occlusion in the event of an SVC tear or perforation during a lead extraction procedure
The Bridge Occlusion Balloon catheter is constructed of a compliant balloon mounted on a dual lumen shaft. This guidewire lumen is used to pass the catheter over a guidewire.
Three platinum-iridium radiopaque markers are placed within the balloon segment of the catheter to provide visual reference points for balloon positioning within the SVC prior to inflation.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
superior vena cava (SVC)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Preclinical data were gathered to demonstrate substantial equivalence of the Bridge Occlusion Balloon when used as intended. The preclinical GLP testing demonstrated that the Bridge Occlusion Balloon meets its intended use of SVC occlusion. No clinical testing was required for the Bridge Occlusion Balloon.
Testing conducted included:
- Design Verification and Validation Testing: Dimensional and Visual Tests (Crossing Profile, Balloon Working Length, Guidewire Compatibility, Catheter Effective Length, Surface Appearance, Distal Tip Configuration, Luer Compatibility)
- Performance Testing: Deployment and Retraction, Inflation and Deflation Time, Balloon Bond Strength, Inflated Balloon Size Stability, Tip Bond Strength, Hub Bond Strength, Flexibility and Kink, Leak Testing, Balloon Burst Volume, Device Fatique
- Sterilization: Half Cycle Validation per ISO 11135
- Biocompatibility: Cytotoxicity, Sensitization, Intracutaneous Reactivity, Acute Systemic Toxicity, C3a Complement Activation, C5b-9 Complement Activation, Direct Hemolysis, Indirect Hemolysis, Partial Thromboplastin Time, Material Mediated Pyrogenicity
Key results: The testing validated and verified that the subject device met all specifications and was substantially equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.4450 Vascular clamp.
(a)
Identification. A vascular clamp is a surgical instrument used to occlude a blood vessel temporarily.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of three human profiles facing right, with flowing lines above them. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the image.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 24, 2016
Spectranetics. Inc. Mr. Christopher McLellan Regulatory Affairs Manager 9965 Federal Drive Colorado Springs, Colorado 80921
Re: K153530
Trade/Device Name: Bridge Occlusion Balloon Regulation Number: 21 CFR 870.4450 Regulation Name: Vascular Clamp Regulatory Class: Class II Product Code: MJN Dated: December 8, 2015 Received: December 9, 2015
Dear Mr. McLellan:
This letter corrects our substantially equivalent letter of February 5, 2016.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
1
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Brian D. Pullin -S
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K153530
Device Name Bridge Occlusion Balloon
Indications for Use (Describe)
The Bridge Occlusion Balloon catheter is indicated for use for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage.
Any use for procedures other than those indicated in the instructions is not recommended.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☒ Prescription Use (Part 21 CFR 801 Subpart D) | □ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/2 description: The image contains the logo for Spectranetics. The logo features a blue diamond shape with a white circle inside on the left. To the right of the diamond is the word "Spectranetics" in a bold, blue font. Below the company name is the tagline "Always Reaching Farther" in a smaller, lighter font.
510(k) Summary
This 510(k) summary was prepared in accordance with 21 CFR 807.92(c) Prepared on December 8, 2015.
| 510(k) Submitter / Holder: | Spectranetics
9965 Federal Drive
Colorado Springs, CO 80921.3617
Establishment Registration No: 3007284006 |
|----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | Christopher McLellan
Regulatory Affairs Manager
Office: 719.447.2475
Mobile: 719.314.8561
Fax: 719.447.2040
Email: christopher.mclellan@spnc.com |
Subject Device
| Device Trade Name: | Bridge Occlusion Balloon |
|---|---|
| Device Common Name: | Catheter, Intravascular Occluding, Temporary |
| Device Class: | II |
| Classification Regulation: | 21 CFR 870.4450 |
| Regulation Description: | Vascular Clamp |
| Product Code: | MJN |
| 510(k) Type: | Traditional |
| Model Number: | 590-001 |
Predicate Device
The Bridge Occlusion Balloon was compared to the following legally marketed predicate device:
| 510(k) Number: | K140273 |
|---|---|
| Manufacturer: | Boston Scientific |
| Trade Name: | Equalizer Occlusion Balloon Catheter |
| Device Common Name: | Catheter, Intravascular Occluding, Temporary |
Device Description
The Bridge Occlusion Balloon is designed to be delivered percutaneously to the superior vena cava (SVC) for the purpose of providing occlusion of the SVC and providing emergency control of hemorrhage and perioperative occlusion in the event of an SVC tear or perforation during a lead extraction procedure
The Bridge Occlusion Balloon catheter is constructed of a compliant balloon mounted on a dual lumen shaft. This guidewire lumen is used to pass the catheter over a guidewire.
Three platinum-iridium radiopaque markers are placed within the balloon segment of the catheter to provide visual reference points for balloon positioning within the SVC prior to inflation.
4
Image /page/4/Picture/2 description: The image shows the Spectranetics logo. The logo consists of a blue diamond shape with a white outline on the left, followed by the word "Spectranetics" in blue, and the tagline "Always Reaching Farther" in black below the word "Spectranetics". The logo is clean and modern, and the colors are bright and eye-catching.
Intended and Indications for Use
The Bridge Occlusion Balloon catheter is indicated for use for temporary vessel occlusion in applications including perioperative occlusion and emergency control of hemorrhage.
Any use for procedures other than those indicated in the instructions is not recommended.
Technological Characteristics
The Bridge Occlusion Balloon is similar in design characteristics and performance to the predicate device. Similar to the predicate, the Bridge Occlusion Balloon is deliverable to the target vasculature and is appropriately sized to perform vascular occlusion procedures. The subject device includes vessel specificity (SVC) in its proposed indication, which differs from the predicate. Performance testing data, including preclinical animal studies have demonstrated that the Bridge Occlusion Balloon is substantially equivalent to the predicate device.
Performance Data
The following testing was conducted to validate and verify that the subject device met all specifications and was substantially equivalent to the predicate device:
Design Verification and Validation Testing
- Dimensional and Visual Tests ●
- o Crossing Profile, Balloon Working Length, Guidewire Compatibility, Catheter Effective Length, Surface Appearance, Distal Tip Configuration, Luer Compatibility
- . Performance Testing
- Deployment and Retraction, Inflation and Deflation Time, Balloon Bond o Strength, Inflated Balloon Size Stability, Tip Bond Strength, Hub Bond Strength, Flexibility and Kink, Leak Testing, Balloon Burst Volume, Device Fatique
Sterilization
- Half Cycle Validation per ISO 11135 .
- Biocompatibility:
- Cytotoxicity ●
- Sensitization ●
- Intracutaneous Reactivity ●
- . Acute Systemic Toxicity
- . C3a Complement Activation
- . SC5b-9 Complement Activation
- Direct Hemolvsis
- Indirect Hemolysis ●
- Partial Thromboplastin Time
- Material Mediated Pyrogenicity
Preclinical and Clinical Data:
Preclinical data were gathered to demonstrate substantial equivalence of the Bridge Occlusion Balloon when used as intended. The preclinical GLP testing demonstrated
5
Image /page/5/Picture/2 description: The image shows the Spectranetics logo. The logo consists of a blue geometric shape on the left, followed by the word "Spectranetics" in a bold, blue font. Below the word "Spectranetics" is the tagline "Always Reaching Farther" in a smaller, lighter font. The logo is clean and modern, and the blue color gives it a sense of trust and reliability.
that the Bridge Occlusion Balloon meets its intended use of SVC occlusion. No clinical testing was required for the Bridge Occlusion Balloon.
Substantial Equivalence
Based on the similarities in design between the subject and predicate devices, and the performance data, the Bridge Occlusion Balloon is substantially equivalent to the legally marketed Equalizer Occlusion Balloon Catheter.